KARMIEL, Israel--(BUSINESS WIRE)--Medgenics (AIM: MEDG), the US incorporated biopharmaceutical company that was admitted to AIM in December 2007, is pleased to announce the appointment of Lord Steinberg to the Company’s Board, as a non-executive director with immediate effect.
